Crown Provides Update on Nasdaq Delisting
Crown Electrokinetics (OTC: CRKN) announced that the Nasdaq Hearings Panel has rejected their request to reconsider its March 3, 2025 decision to delist the company's common stock from The Nasdaq Stock Market. In response, Crown filed an appeal on March 18, 2025, seeking further review of the delisting decision.
The company has transitioned to trading on the OTC market and is working with market makers and advisors to maintain efficient trading and liquidity for shareholders. CEO Doug Croxall stated that while the outcome was not preferred, the company continues to focus on executing its business strategy and delivering long-term value for shareholders.
Crown aims to eventually return to a national exchange when appropriate while maintaining its focus on growth strategy and operational efficiency in the infrastructure solutions sector.
Crown Electrokinetics (OTC: CRKN) ha annunciato che il Nasdaq Hearings Panel ha respinto la richiesta di riesame della decisione del 3 marzo 2025 di delistare le azioni ordinarie della società dal Nasdaq Stock Market. In risposta, Crown ha presentato un appello il 18 marzo 2025, chiedendo un ulteriore riesame della decisione di delistare.
La società è passata a operare sul mercato OTC e sta collaborando con i market maker e consulenti per mantenere un trading efficiente e una liquidità per gli azionisti. Il CEO Doug Croxall ha dichiarato che, sebbene l'esito non sia stato quello desiderato, la società continua a concentrarsi sull'esecuzione della propria strategia aziendale e sulla creazione di valore a lungo termine per gli azionisti.
Crown punta a tornare eventualmente a un mercato nazionale quando sarà opportuno, mantenendo al contempo il focus sulla strategia di crescita e sull'efficienza operativa nel settore delle soluzioni infrastrutturali.
Crown Electrokinetics (OTC: CRKN) anunció que el Panel de Audiencias de Nasdaq ha rechazado su solicitud de reconsiderar la decisión del 3 de marzo de 2025 de excluir las acciones ordinarias de la compañía del Nasdaq Stock Market. En respuesta, Crown presentó una apelación el 18 de marzo de 2025, buscando una revisión adicional de la decisión de exclusión.
La compañía ha pasado a operar en el mercado OTC y está trabajando con creadores de mercado y asesores para mantener un comercio eficiente y liquidez para los accionistas. El CEO Doug Croxall declaró que, aunque el resultado no fue el preferido, la compañía sigue enfocándose en ejecutar su estrategia empresarial y ofrecer valor a largo plazo a los accionistas.
Crown tiene como objetivo eventualmente regresar a un intercambio nacional cuando sea apropiado, manteniendo su enfoque en la estrategia de crecimiento y la eficiencia operativa en el sector de soluciones de infraestructura.
Crown Electrokinetics (OTC: CRKN)은 Nasdaq 청문 위원회가 2025년 3월 3일 회사의 보통주를 Nasdaq 증권 시장에서 상장 폐지하겠다는 결정을 재고해 달라는 요청을 거부했다고 발표했습니다. 이에 따라 Crown은 2025년 3월 18일 상장 폐지 결정에 대한 추가 검토를 요청하는 항소를 제기했습니다.
회사는 OTC 시장에서 거래하도록 전환했으며, 시장 조성자 및 자문가와 협력하여 주주를 위한 효율적인 거래와 유동성을 유지하고 있습니다. CEO Doug Croxall은 결과가 바람직하지는 않았지만, 회사는 여전히 비즈니스 전략을 실행하고 주주에게 장기 가치를 제공하는 데 집중하고 있다고 밝혔습니다.
Crown은 적절할 때 국가 거래소로 돌아가는 것을 목표로 하며, 인프라 솔루션 분야에서 성장 전략과 운영 효율성에 집중하고 있습니다.
Crown Electrokinetics (OTC: CRKN) a annoncé que le panel des audiences de Nasdaq avait rejeté sa demande de réexamen de sa décision du 3 mars 2025 de retirer les actions ordinaires de la société du Nasdaq Stock Market. En réponse, Crown a déposé un appel le 18 mars 2025, demandant un examen supplémentaire de la décision de retrait.
La société a changé pour négocier sur le marché OTC et travaille avec des teneurs de marché et des conseillers pour maintenir un trading efficace et une liquidité pour les actionnaires. Le PDG Doug Croxall a déclaré que, bien que le résultat ne soit pas celui souhaité, la société continue de se concentrer sur l'exécution de sa stratégie commerciale et la création de valeur à long terme pour les actionnaires.
Crown vise à revenir éventuellement à une bourse nationale lorsque cela sera approprié, tout en maintenant son attention sur la stratégie de croissance et l'efficacité opérationnelle dans le secteur des solutions d'infrastructure.
Crown Electrokinetics (OTC: CRKN) gab bekannt, dass das Nasdaq Hearings Panel ihren Antrag auf Überprüfung der Entscheidung vom 3. März 2025, die Stammaktien des Unternehmens vom Nasdaq Stock Market zu delistieren, abgelehnt hat. Als Reaktion darauf hat Crown am 18. März 2025 Berufung eingelegt und eine weitere Prüfung der Delisting-Entscheidung beantragt.
Das Unternehmen hat auf den OTC-Markt umgestellt und arbeitet mit Market Makern und Beratern zusammen, um einen effizienten Handel und Liquidität für die Aktionäre aufrechtzuerhalten. CEO Doug Croxall erklärte, dass, obwohl das Ergebnis nicht bevorzugt wurde, das Unternehmen weiterhin darauf fokussiert ist, seine Geschäftsstrategie umzusetzen und langfristigen Wert für die Aktionäre zu schaffen.
Crown strebt an, schließlich zu einer nationalen Börse zurückzukehren, wenn es angemessen ist, und behält gleichzeitig den Fokus auf Wachstumsstrategien und operative Effizienz im Bereich der Infrastrukturlösungen bei.
- Maintained trading continuity through transition to OTC markets
- Company continues normal operations despite delisting
- Delisting from Nasdaq, potentially reducing stock visibility and institutional investor access
- Appeal rejection by Nasdaq Hearings Panel indicates serious compliance issues
- Downgrade to OTC markets may result in reduced trading liquidity
LOS ANGELES, March 19, 2025 (GLOBE NEWSWIRE) -- Crown Electrokinetics Corp. (OTC: CRKN) ("Crown" or the "Company”), a leading provider of innovative technology infrastructure solutions that benefit communities and the environment, today announced that the Nasdaq Hearings Panel has declined Crown’s request to reconsider its March 3, 2025, decision to delist the Company’s common stock from The Nasdaq Stock Market. Following this determination, Crown immediately prepared and filed an appeal on March 18, 2025, requesting further review of the delisting decision. While this appeal does not guarantee reinstatement, it represents the next step in the process with Nasdaq.
“While we would have preferred a different outcome from the Nasdaq Hearings Panel, we remain focused on executing our business strategy and delivering long-term value for our shareholders. Our operations continue as normal, and we are making solid progress on our key initiatives. Crown is actively trading on the OTC market, and we appreciate the continued support from our investors as we move forward. We will provide further updates as appropriate,” said Doug Croxall, CEO and Chairman, Crown.
Crown remains committed to ensuring efficient trading and liquidity for its shareholders following the transition to the OTC market. The Company continues to work with its market makers and advisors to facilitate a smooth trading experience for investors.
Looking ahead, Crown continues to evaluate all available options regarding its listing status and intends to pursue a return to a national exchange when appropriate. The Company remains focused on executing its growth strategy, driving operational efficiency, and capitalizing on the opportunities ahead in critical infrastructure solutions.
About Crown
Crown is an innovative infrastructure solutions provider dedicated to benefiting communities and the environment. Operating across multiple businesses – Smart Windows, and Construction – Crown is developing and delivering cutting edge solutions that are challenging the status quo and redefining industry standards. For more information, please visit www.crownek.com.
Forward-Looking Statements
Certain statements in this news release may be "forward-looking statements" (within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995) regarding future events or Crown’s future financial performance that involve certain contingencies and uncertainties, including those discussed in Crown’s Annual Report on Form 10-K for the year ended December 31, 2023, and subsequent reports Crown files with the U.S. Securities and Exchange Commission from time to time, in the sections entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” . Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Crown Electrokinetic Corporation undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
For more information, please contact:
Investor Relations
ir@crownek.com
Public Relations
pr@crownek.com
FAQ
When was Crown Electrokinetics (CRKN) delisted from Nasdaq?
What is Crown Electrokinetics' (CRKN) current trading status after Nasdaq delisting?
When did Crown Electrokinetics (CRKN) file their appeal against the Nasdaq delisting?
What are Crown Electrokinetics' (CRKN) plans regarding future exchange listing?
